BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10647230)

  • 1. A case for comprehensive antenatal screening for blood group antibodies.
    Anwar M; Ali N; Khattak MF; Raashid Y; Karamat KA
    J Pak Med Assoc; 1999 Oct; 49(10):246-8. PubMed ID: 10647230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.
    Yasuda H; Ohto H; Nollet KE; Kawabata K; Saito S; Yagi Y; Negishi Y; Ishida A
    Transfus Med Rev; 2014 Jan; 28(1):1-6. PubMed ID: 24262303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Irregular blood group antibodies during pregnancy: screening is mandatory].
    Semmekrot BA; de Man AJ; Boekkooi PF; van Dijk BA
    Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1449-52. PubMed ID: 10443258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The incidence of irregular antibodies in pregnancy: a prospective study in the region of the 's-Hertogenbosch].
    de Vrijer B; Harthoorn-Lasthuizen EJ; Oosterbaan HP
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2523-7. PubMed ID: 10627755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory identification of erythroblastosis fetalis.
    Kurtz EM; Pappas AA; Cannon A
    Ann Clin Lab Sci; 1982; 12(5):388-97. PubMed ID: 6814344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of hemolytic disease of the newborn due to anti-Dib antibodies.
    Uchikawa M; Shibata Y; Tohyama H; Mori H; Aisaka K; Nakagawa M
    Vox Sang; 1982 Feb; 42(2):91-2. PubMed ID: 7199783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hydrops fetalis caused by isoimmunization against Kell factor (author's transl)].
    Mattern H; Seifert H
    Klin Padiatr; 1980 Sep; 192(5):485-7. PubMed ID: 7192346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemolytic disease of the newborn due to anti-K antibodies.
    de Jonge N; Martens JE; Milani AL; Krijnen JL; van Krimpen C; Ponjee GA
    Eur J Obstet Gynecol Reprod Biol; 1996 Jul; 67(1):69-72. PubMed ID: 8789754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythroblastosis fetalis with hydrops resulting from anti-Kell isoimmune disease.
    Frigoletto FD; Davies IJ
    Am J Obstet Gynecol; 1977 Apr; 127(8):887. PubMed ID: 851149
    [No Abstract]   [Full Text] [Related]  

  • 11. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent fetal hydrops with maternal M alloimmunisation: not a benign condition.
    Yu M; Graham K; Pasalic L; Alahakoon TI
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31331930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Rh0 (D) hemolytic disease of the newborn: an obstetric viewpoint.
    Zlatnik FJ
    Semin Perinatol; 1977 Apr; 1(2):169-75. PubMed ID: 754292
    [No Abstract]   [Full Text] [Related]  

  • 14. ABO-haemolytic disease of the newborn (ABO-HDN): factors influencing its severity and incidence in Venezuela.
    Cariani L; Romano EL; Martínez N; Montaño R; Suarez G; Ruiz I; Soyano A
    J Trop Pediatr; 1995 Feb; 41(1):14-21. PubMed ID: 7723123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anemic Disease of the Newborn With Little Increase in Hemolysis and Erythropoiesis Due to Maternal Anti-Jr
    Katsuragi S; Ohto H; Yoshida A; Otake A; Tsuneyama H; Ogasawara K; Isa K; Ikeda T
    Transfus Med Rev; 2019 Jul; 33(3):183-188. PubMed ID: 31227265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Incidence, laboratory diagnosis and serologic prediction of hemolytic disease of newborn infants due to ABO incompatibility].
    Schönitzer D; Frisch H
    Padiatr Padol; 1984; 19(3):263-78. PubMed ID: 6472867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood group immunization: results of treatment of fetal anemia with intra-uterine intravascular blood transfusion in the Netherlands, 1987-1995].
    van Kamp IL; Klumper FJ; Meerman RH; Brand A; Bennebroek Gravenhorst J; Kanhai HH
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2527-31. PubMed ID: 10627756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management.
    Wenk RE; Goldstein P; Felix JK
    Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two neonates with severe rhesus antagonism inspite of low values in recent tests of antibody dependent cellular cytotoxicity (ADCC)].
    Janssens LP; Koolen AM; Oei SG; Overbeeke MA
    Ned Tijdschr Geneeskd; 1999 Sep; 143(36):1823-6. PubMed ID: 10526587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemolytic disease of newborn.
    Narang A; Jain N
    Indian J Pediatr; 2001 Feb; 68(2):167-72. PubMed ID: 11284186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.